Cronos Group (CVE:MJN) Stock Price Down 1.9% – Here’s Why
by Tristan Rich · The Markets DailyShares of Cronos Group Inc (CVE:MJN – Get Free Report) fell 1.9% during trading on Tuesday . The company traded as low as C$11.90 and last traded at C$12.15. 1,388,975 shares were traded during trading, a decline of 33% from the average session volume of 2,065,952 shares. The stock had previously closed at C$12.38.
Cronos Group Stock Down 1.9%
The firm’s 50 day moving average price is C$12.15 and its two-hundred day moving average price is C$12.15.
About Cronos Group
Cronos Group Inc, formerly PharmaCan Capital Corp, is a Canada-based cannabis company. The Company operates two Licensed Producers (LPs) regulated within Health Canada’s Access to Cannabis for Medical Purposes Regulations (the ACMPR) and holds a portfolio of investments in other Licensed Producers and ACMPR applicants. Its LPs, Peace Naturals Project Inc and In The Zone Produce Ltd., are collectively located on over 125 acres of agricultural land. It also holds equity positions in Licensed Producers Whistler Medical Marijuana, Hydropothecary and Abcann Medicinals.
Read More
- Five stocks we like better than Cronos Group
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
- Paychex Plunges, Providing the Entry Investors Have Been Waiting For
- The Case for Buying High-Yield General Mills Just Strengthened
- SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story